Civic Intelligence

Cureshank

EIN 84-2240648 • 501(c)3 • Beverly Hills, CA

Profile

To accelerate the development of treatments for phelan-mcdermid syndrome and shank-related disorders. Our approach is to identify and fund projects that overcome critical barriers to successful drug development and to coordinate scientific efforts to improve efficiency and speed in the field.

433 N Camden Drive 1100Beverly Hills, CA 90210

www.cureshank.org

Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

30th percentile

0.01x

Higher debt load relative to assets than 30% of similar nonprofits.

501(c)3 • $1M-$5M nonprofits • Source year 2024

Liabilities / Revenue

31st percentile

0.01x

Higher debt load relative to revenue than 31% of similar nonprofits.

501(c)3 • $1M-$5M nonprofits • Source year 2024

Net Margin

63rd percentile

12%

Higher net margin than 63% of similar nonprofits.

501(c)3 • $1M-$5M nonprofits • Source year 2024

Top Officer Pay

40th percentile

$0

Higher top officer pay than 40% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

501(c)3 • $1M-$5M nonprofits • Source year 2024

Asset Growth

60th percentile

7.3%

Faster asset growth than 60% of similar nonprofits.

501(c)3 • $1M-$5M nonprofits • Annualized from 2023 to 2024

Revenue Growth

74th percentile

29%

Faster revenue growth than 74% of similar nonprofits.

501(c)3 • $1M-$5M nonprofits • Annualized from 2023 to 2024

Balance Sheet
Liabilities / Assets30th percentile

Assets

Up

$1,118,841

Up $76,456 (+7.3%) from 2023

Liabilities

Up

$7,162

Up $6,800 (+1878%) from 2023

Net Assets

Up

$1,111,679

Up $69,656 (+6.7%) from 2023

Operations
Liabilities / Revenue31st percentileNet Margin63rd percentile

Revenue

Up

$597,811

Up $132,839 (+29%) from 2023

Expenses

Up

$528,155

Up $240,187 (+83%) from 2023

Net Income

Down

$69,656

Down $107,348 (-61%) from 2023

Trend Graphs

Balance Sheet Trend

Asset Growth60th percentile

Grouped bars show assets, liabilities, and net assets across loaded filings.

$1.5M$1.0M$500K$0Assets 2019: $20,766Net Assets 2019: $20,7662019Assets 2020: $57,028Liabilities 2020: $02020Assets 2021: $586,406Liabilities 2021: $0Net Assets 2021: $586,4062021Assets 2022: $854,048Liabilities 2022: $0Net Assets 2022: $854,0482022Assets 2023: $1,042,385Liabilities 2023: $362Net Assets 2023: $1,042,0232023Assets 2024: $1,118,841Liabilities 2024: $7,162Net Assets 2024: $1,111,6792024

Highlighted filing

2024

Assets$1,118,841
Liabilities$7,162
Net Assets$1,111,679
Open 2024 Filing

Operations Trend

Revenue Growth74th percentile

Revenue, expenses, and net income by year, with the latest filing highlighted.

$600K$400K$200K$0Revenue 2019: $24,550Expenses 2019: $3,784Net Income 2019: $20,7662019Revenue 2020: $46,065Expenses 2020: $7,939Net Income 2020: $38,1262020Revenue 2021: $547,552Expenses 2021: $18,174Net Income 2021: $529,3782021Revenue 2022: $487,302Expenses 2022: $219,660Net Income 2022: $267,6422022Revenue 2023: $464,972Expenses 2023: $287,968Net Income 2023: $177,0042023Revenue 2024: $597,811Expenses 2024: $528,155Net Income 2024: $69,6562024

Highlighted filing

2024

Revenue$597,811
Expenses$528,155
Net Income$69,656
Open 2024 Filing

Filings

Most recent year

2024 • Form 990XML pending. An XML filing is linked for this year, but detailed extraction is still pending.

Open filing
Assets
$1,118,841
Liabilities
$7,162
Net assets
$1,111,679
Revenue
$597,811
Expenses
$528,155
Net income
$69,656
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$1.12$0.01$1.11$0.60$0.53$0.07
2023Summary only. Only limited summary data is available for this year.$1.04$0.00$1.04$0.46$0.29$0.18
2022Facts available. Structured filing facts are available, but richer extracted sections are limited.$0.85$0.00$0.85$0.49$0.22$0.27
2021XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.59$0.00$0.59$0.55$0.02$0.53
2020Summary only. Only limited summary data is available for this year.$0.06$0.00$0.05$0.01$0.04
2019XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.02$0.02$0.02$0.00$0.02
Latest Detailed Filing

The latest 2024 filing currently has linked XML that has not been fully parsed yet. Showing the latest detailed filing from 2022 below.

Jump To
Filing Snapshot
Filing Period
Jan 1, 2022 to Dec 31, 2022
Signed
Nov 1, 2023
Return Version
2022v5.0
Gross Receipts
$487,302
Mission and Program Overview

Mission

The specific purpose of this corporation is to foster the development of treatments and cures for SHANK-related disorders.

To accelerate the development of treatments for phelan-mcdermid syndrome and shank-related disorders.

Balance Sheet Detail
LineBeginningEndChange
Assets
Cash and Non-Interest-Bearing Accounts$437,681$853,047▲ $415,366
Savings and Temporary Cash Investments$148,725$1,001▼ $147,724
Total Assets$586,406$854,048▲ $267,642
Liabilities
Total Liabilities$0$0→ $0
Net Assets / Fund Balance
Net Assets Without Donor Restrictions$586,406$854,048▲ $267,642
Total Net Assets Fund Balance$586,406$854,048▲ $267,642
Total Liabilities and Net Assets / Fund Balance$586,406$854,048▲ $267,642
Compensation and Service Providers
Top Officer Pay40th percentile

Board Members and Trustees

NameTitle
Geraldine BlissPresident
Talya Emery SilvaVice President
Paulina RychenkovaSecretary
Abby LievenseTreasurer
Revenue and Support

Revenue Composition

Contributions and Grants
$487,299
Program Service Revenue
$0
Investment Income
$3
Other Revenue
$0
All Other Contributions
$487,299
Change in Net Assets
$267,642
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Other Expenses$214,660
Grants and Similar Amounts Paid$5,000
Professional Fundraising Fees$0
Salaries, Compensation, and Employee Benefits$0
Total Fundraising Expense$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Fees for Services Management$147,808--$147,808
Fees for Services Legal$30,067--$30,067
Advertising-$16,919-$16,919
Grants to Domestic Orgs$5,000--$5,000
Travel-$3,507-$3,507
Occupancy-$2,644-$2,644
Insurance-$1,291-$1,291
Other Expenses$900--$900
Fees for Services Accounting-$680-$680
Office Expenses-$544-$544
Total Functional Expenses$194,075$25,585$0$219,660
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
No
Other officer compensation reviewed
No
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section B, Line 11B

“A copy of form 990 is provided to the governing body via email before it is filed.”

Form 990, Part VI, Section C, Line 19

“UPON REQUEST.”

Filing and Contact Details

Filer

Filer Name
Cureshank
EIN
84-2240648
Phone
3104098060
Address
433 N CAMDEN DRIVE 1100, BEVERLY HILLS, CA 90210

Signing Officer

Name
Abby Lievense
Title
Treasurer
Phone
3104098060
Signed
2023-11-01
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Geraldine Bliss
Formed
2019
Legal Domicile
CA
Voting Board Members
4
Independent Board Members
4
Employees
0
Volunteers
4

Preparer

Firm
Jacobson Jarvis & Co Pllc
Address
200 1ST AVE W SUITE 200, SEATTLE, WA 98119
Preparer
Howard Donkin
Phone
2066288990
Supplemental Narrative

Additional Explanations

Form 990, Part III, Line 2

“The cureshank biomarkers and outcome measures consortium facilitates a cooperative, globally aligned effort focused on the identification and development of novel approaches to enable successful clinical trials for phelan-mcdermid syndrome. The consortium establishes a pre-competitive space for companies to advance biomarker research efforts and outcome measures in phelan-mcdermid syndrome.”

Raw XML Appendix328 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0TO ACCELERATE THE DEVELOPMENT OF TREATMENTS FOR PHELAN-MCDERMID SYNDROME AND SHANK-RELATED DISORDERS.
IRS990/AdvertisingGrp/ManagementAndGeneralAmt016919
IRS990/AdvertisingGrp/TotalAmt016919
IRS990/AllOtherContributionsAmt0487299
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0ABBY LIEVENSE
IRS990/BooksInCareOfDetail/PhoneNum03104098060
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt0433 N CAMDEN DRIVE 1100
IRS990/BooksInCareOfDetail/USAddress/CityNm0BEVERLY HILLS
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0CA
IRS990/BooksInCareOfDetail/USAddress/ZIPCd090210
IRS990/BusinessRlnWith35CtrlEntInd00
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CashNonInterestBearingGrp/BOYAmt0437681
IRS990/CashNonInterestBearingGrp/EOYAmt0853047
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt00
IRS990/CollectionsOfArtInd00
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd00
IRS990/CompensationProcessOtherInd00
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd00
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt0487299
IRS990/CYGrantsAndSimilarPaidAmt05000
IRS990/CYInvestmentIncomeAmt03
IRS990/CYOtherExpensesAmt0214660
IRS990/CYOtherRevenueAmt00
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt0267642
IRS990/CYSalariesCompEmpBnftPaidAmt00
IRS990/CYTotalExpensesAmt0219660
IRS990/CYTotalFundraisingExpenseAmt00
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt0487302
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd00
IRS990/DelegationOfMgmtDutiesInd00
IRS990/Desc0CURESHANK WILL BRING THE SCIENTIFIC COMMUNITY TOGETHER BY ORGANIZING SCIENTIFIC SYMPOSIA AND OTHER MEETINGS. WITH OUR SCIENTIFIC STAKEHOLDERS, WE WILL DEVELOP A RESEARCH ROADMAP TO A CURE FOR SHANK-RELATED DISORDERS. WE WILL ALSO SERVE AS AN HONEST BROKER TO ENABLE COLLABORATION AMONG SHANK RESEARCHERS AND COORDINATION OF THEIR PROJECTS TO IMPROVE THE SPEED AND EFFICIENCY OF RESEARCH.
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd00
IRS990/DonorAdvisedFundInd00
IRS990/DonorRstrOrQuasiEndowmentsInd00
IRS990/ElectionOfBoardMembersInd00
IRS990/EmployeeCnt00
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt0107292
IRS990/FamilyOrBusinessRlnInd00
IRS990/FederalGrantAuditRequiredInd00
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt0680
IRS990/FeesForServicesAccountingGrp/TotalAmt0680
IRS990/FeesForServicesLegalGrp/ProgramServicesAmt030067
IRS990/FeesForServicesLegalGrp/TotalAmt030067
IRS990/FeesForServicesManagementGrp/ProgramServicesAmt0147808
IRS990/FeesForServicesManagementGrp/TotalAmt0147808
IRS990/ForeignActivitiesInd00
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignOfficeInd00
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt040.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt125.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt215.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt35.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OfficerInd3X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/PersonNm0GERALDINE BLISS
IRS990/Form990PartVIISectionAGrp/PersonNm1PAULINA RYCHENKOVA
IRS990/Form990PartVIISectionAGrp/PersonNm2ABBY LIEVENSE
IRS990/Form990PartVIISectionAGrp/PersonNm3TALYA EMERY SILVA
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/TitleTxt0PRESIDENT
IRS990/Form990PartVIISectionAGrp/TitleTxt1SECRETARY
IRS990/Form990PartVIISectionAGrp/TitleTxt2TREASURER
IRS990/Form990PartVIISectionAGrp/TitleTxt3VICE PRESIDENT
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/FormationYr02019
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedInd00
IRS990/FundraisingActivitiesInd00
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt04
IRS990/GrantAmt05000
IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt05000
IRS990/GrantsToDomesticOrgsGrp/TotalAmt05000
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd01
IRS990/GrantToRelatedPersonInd00
IRS990/GrossReceiptsAmt0487302
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd00
IRS990/IndependentAuditFinclStmtInd00
IRS990/IndependentVotingMemberCnt04
IRS990/IndivRcvdGreaterThan100KCnt00
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InsuranceGrp/ManagementAndGeneralAmt01291
IRS990/InsuranceGrp/TotalAmt01291
IRS990/InvestmentIncomeGrp/ExclusionAmt03
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt03
IRS990/InvestmentInJointVentureInd00
IRS990/IRPDocumentCnt00
IRS990/IRPDocumentW2GCnt00
IRS990/LegalDomicileStateCd0CA
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd00
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd00
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0TO ACCELERATE THE DEVELOPMENT OF TREATMENTS FOR PHELAN-MCDERMID SYNDROME AND SHANK-RELATED DISORDERS. OUR APPROACH IS TO IDENTIFY AND FUND PROJECTS THAT OVERCOME CRITICAL BARRIERS TO SUCCESSFUL DRUG DEVELOPMENT AND TO COORDINATE SCIENTIFIC EFFORTS TO IMPROVE EFFICIENCY AND SPEED IN THE FIELD.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd00
IRS990/NetAssetsOrFundBalancesBOYAmt0586406
IRS990/NetAssetsOrFundBalancesEOYAmt0854048
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt0586406
IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt0854048
IRS990/NoListedPersonsCompensatedInd0X
IRS990/NondeductibleContributionsInd00
IRS990/OccupancyGrp/ManagementAndGeneralAmt02644
IRS990/OccupancyGrp/TotalAmt02644
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt0544
IRS990/OfficeExpensesGrp/TotalAmt0544
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsFASB117Ind0X
IRS990/OtherChangesInNetAssetsAmt00
IRS990/OtherExpensesGrp/Desc0CONCEPTUAL MODEL
IRS990/OtherExpensesGrp/Desc1FAMILY STORIES
IRS990/OtherExpensesGrp/Desc2VOICE OF PATIENT REPORT
IRS990/OtherExpensesGrp/Desc3MEMBERSHIP FEES
IRS990/OtherExpensesGrp/ProgramServicesAmt03700
IRS990/OtherExpensesGrp/ProgramServicesAmt13600
IRS990/OtherExpensesGrp/ProgramServicesAmt23000
IRS990/OtherExpensesGrp/ProgramServicesAmt3900
IRS990/OtherExpensesGrp/TotalAmt03700
IRS990/OtherExpensesGrp/TotalAmt13600
IRS990/OtherExpensesGrp/TotalAmt23000
IRS990/OtherExpensesGrp/TotalAmt3900
IRS990/PartialLiquidationInd00
IRS990/PayPremiumsPrsnlBnftCntrctInd00
IRS990/PoliticalCampaignActyInd00
IRS990/PrincipalOfficerNm0GERALDINE BLISS
IRS990/ProfessionalFundraisingInd00
IRS990/ProgSrvcAccomActy2Grp/Desc0CURESHANK WILL FUND TARGETED RESEARCH STUDIES, INCLUDING SCIENTIFIC PROJECTS THAT ELUCIDATE THE UNDERLYING DISEASE MECHANISMS, THAT IDENTIFY AND VALIDATE TARGETS FOR DRUG DEVELOPMENT, AND THAT DE-RISK PROMISING DRUG TARGETS. CURESHANK WILL ALSO FUND CERTAIN PROMISING CLINICAL TRIALS READINESS INITIATIVES. THESE ACTIVITIES ARE NEEDED TO INCREASE THE NUMBER OF DRUG TARGETS MOVING FROM ACADEMIC RESEARCH LABS INTO SUCCESSFUL INDUSTRY-SPONSORED CLINICAL TRIALS.
IRS990/ProgSrvcAccomActy2Grp/ExpenseAmt085883
IRS990/ProgSrvcAccomActy3Grp/Desc0CURESHANK WILL ADVOCATE FOR INCREASED FUNDING OF SHANK RESEARCH BY OTHER STAKEHOLDERS AND STRATEGIZE WITH RESEARCHERS ON INITIATIVES, SUCH AS SEED GRANTS, THAT COULD HELP ATTRACT RESEARCH INVESTMENT BY OTHER FUNDERS.
IRS990/ProgSrvcAccomActy3Grp/ExpenseAmt0900
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt0547552
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt0500
IRS990/PYInvestmentIncomeAmt00
IRS990/PYOtherExpensesAmt017674
IRS990/PYOtherRevenueAmt00
IRS990/PYProgramServiceRevenueAmt00
IRS990/PYRevenuesLessExpensesAmt0529378
IRS990/PYSalariesCompEmpBnftPaidAmt00
IRS990/PYTotalExpensesAmt018174
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt0547552
IRS990/QuidProQuoContributionsInd00
IRS990/RcvFndsToPayPrsnlBnftCntrctInd00
IRS990/ReconcilationRevenueExpnssAmt0267642
IRS990/RegularMonitoringEnfrcInd00
IRS990/RelatedEntityInd00
IRS990/RelatedOrganizationCtrlEntInd00
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd00
IRS990/ReportOtherAssetsInd00
IRS990/ReportOtherLiabilitiesInd00
IRS990/ReportProgramRelatedInvstInd00
IRS990/SavingsAndTempCashInvstGrp/BOYAmt0148725
IRS990/SavingsAndTempCashInvstGrp/EOYAmt01001
IRS990ScheduleA/First5Years170Ind0X
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt0487298
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt0547552
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt040500
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt024550
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt01099900
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt03
IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt03
IRS990ScheduleA/OtherIncome170Grp/CurrentTaxYearMinus2YearsAmt05565
IRS990ScheduleA/OtherIncome170Grp/TotalAmt05565
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportTotal170Amt0920990
IRS990ScheduleA/SubstantialContributorsTotAmt0178910
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt0487298
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt0547552
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt040500
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt024550
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt01099900
IRS990ScheduleA/TotalSupportAmt01105468
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990/ScheduleBRequiredInd01
IRS990ScheduleI/GrantRecordsMaintainedInd00
IRS990/ScheduleJRequiredInd00
IRS990/ScheduleORequiredInd01
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0THE CURESHANK BIOMARKERS AND OUTCOME MEASURES CONSORTIUM FACILITATES A COOPERATIVE, GLOBALLY ALIGNED EFFORT FOCUSED ON THE IDENTIFICATION AND DEVELOPMENT OF NOVEL APPROACHES TO ENABLE SUCCESSFUL CLINICAL TRIALS FOR PHELAN-MCDERMID SYNDROME. THE CONSORTIUM ESTABLISHES A PRE-COMPETITIVE SPACE FOR COMPANIES TO ADVANCE BIOMARKER RESEARCH EFFORTS AND OUTCOME MEASURES IN PHELAN-MCDERMID SYNDROME.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1A COPY OF FORM 990 IS PROVIDED TO THE GOVERNING BODY VIA EMAIL BEFORE IT IS FILED.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2UPON REQUEST.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990, PART III, LINE 2
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990, PART VI, SECTION B, LINE 11B
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990, PART VI, SECTION C, LINE 19
IRS990/SchoolOperatingInd00
IRS990/SignificantChangeInd00
IRS990/SignificantNewProgramSrvcInd01
IRS990/StatesWhereCopyOfReturnIsFldCd0CA
IRS990/SubjectToExcsTaxNetInvstIncInd00
IRS990/SubjectToProxyTaxInd00
IRS990/SubjToTaxRmnrtnExPrchtPymtInd00
IRS990/TaxablePartyNotificationInd00
IRS990/TaxExemptBondsInd00
IRS990/TerminateOperationsInd00
IRS990/TotalAssetsBOYAmt0586406
IRS990/TotalAssetsEOYAmt0854048
IRS990/TotalAssetsGrp/BOYAmt0586406
IRS990/TotalAssetsGrp/EOYAmt0854048
IRS990/TotalCompGreaterThan150KInd00
IRS990/TotalContributionsAmt0487299
IRS990/TotalEmployeeCnt00
IRS990/TotalFunctionalExpensesGrp/FundraisingAmt00
IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt025585
IRS990/TotalFunctionalExpensesGrp/ProgramServicesAmt0194075
IRS990/TotalFunctionalExpensesGrp/TotalAmt0219660
IRS990/TotalGrossUBIAmt00
IRS990/TotalLiabilitiesBOYAmt00
IRS990/TotalLiabilitiesEOYAmt00
IRS990/TotalLiabilitiesGrp/BOYAmt00
IRS990/TotalLiabilitiesGrp/EOYAmt00
IRS990/TotalNetAssetsFundBalanceGrp/BOYAmt0586406
IRS990/TotalNetAssetsFundBalanceGrp/EOYAmt0854048
IRS990/TotalOtherCompensationAmt00
IRS990/TotalProgramServiceExpensesAmt0194075
IRS990/TotalReportableCompFromOrgAmt00
IRS990/TotalRevenueGrp/ExclusionAmt03
IRS990/TotalRevenueGrp/RelatedOrExemptFuncIncomeAmt00
IRS990/TotalRevenueGrp/TotalRevenueColumnAmt0487302
IRS990/TotalRevenueGrp/UnrelatedBusinessRevenueAmt00
IRS990/TotalVolunteersCnt04
IRS990/TotLiabNetAssetsFundBalanceGrp/BOYAmt0586406
IRS990/TotLiabNetAssetsFundBalanceGrp/EOYAmt0854048
IRS990/TotReportableCompRltdOrgAmt00
IRS990/TravelGrp/ManagementAndGeneralAmt03507
IRS990/TravelGrp/TotalAmt03507
IRS990/TrnsfrExmptNonChrtblRltdOrgInd00
IRS990/TypeOfOrganizationCorpInd0X
IRS990/UnrelatedBusIncmOverLimitInd00
IRS990/UponRequestInd0X
IRS990/USAddress/AddressLine1Txt0433 N CAMDEN DRIVE 1100
IRS990/USAddress/CityNm0BEVERLY HILLS
IRS990/USAddress/StateAbbreviationCd0CA
IRS990/USAddress/ZIPCd090210
IRS990/VotingMembersGoverningBodyCnt04
IRS990/VotingMembersIndependentCnt04
IRS990/WebsiteAddressTxt0WWW.CURESHANK.ORG
IRS990/WhistleblowerPolicyInd00
ReturnHeader/AdditionalFilerInformation/TrustedCustomerGrp/AuthenticationAssuranceLevelCd0AAL1
ReturnHeader/AdditionalFilerInformation/TrustedCustomerGrp/IdentityAssuranceLevelCd0IAL1
ReturnHeader/AdditionalFilerInformation/TrustedCustomerGrp/TrustedCustomerCd03
ReturnHeader/BuildTS02023-04-26 12:10:37Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd01
ReturnHeader/BusinessOfficerGrp/PersonNm0ABBY LIEVENSE
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0TREASURER
ReturnHeader/BusinessOfficerGrp/PhoneNum03104098060
ReturnHeader/BusinessOfficerGrp/SignatureDt02023-11-01
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0CURESHANK
ReturnHeader/Filer/BusinessNameControlTxt0CURE
ReturnHeader/Filer/EIN0842240648
ReturnHeader/Filer/PhoneNum03104098060
ReturnHeader/Filer/USAddress/AddressLine1Txt0433 N CAMDEN DRIVE 1100
ReturnHeader/Filer/USAddress/CityNm0BEVERLY HILLS
ReturnHeader/Filer/USAddress/StateAbbreviationCd0CA
ReturnHeader/Filer/USAddress/ZIPCd090210
ReturnHeader/IRSResponsiblePrtyInfoCurrInd00
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0912011386
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0JACOBSON JARVIS & CO PLLC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt0200 1ST AVE W SUITE 200
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0SEATTLE
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0WA
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd098119
ReturnHeader/PreparerPersonGrp/PhoneNum02066288990
ReturnHeader/PreparerPersonGrp/PreparationDt02023-11-01
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0HOWARD DONKIN
ReturnHeader/ReturnTs02023-11-09T15:41:19-06:00
ReturnHeader/ReturnTypeCd0990
ReturnHeader/SigningOfficerGrp/PersonFullName/PersonFirstNm0ABBY
ReturnHeader/SigningOfficerGrp/PersonFullName/PersonLastNm0LIEVENSE
ReturnHeader/TaxPeriodBeginDt02022-01-01
ReturnHeader/TaxPeriodEndDt02022-12-31
ReturnHeader/TaxYr02022

Document Assets

No mirrored PDF or thumbnail assets are attached yet.